CURE Pharmaceutical is kicking off a first-ever clinical study to research cannabinoid compounds to treat leukemia and prostate cancer. More specifically, the company and its partner, Technion-Israel Institute of Technology, will be testing to see if these cannabinoid molecules will attack tumorous cancer cells.
Right now, research on the subject is mostly limited to anecdotal testimonies from patients like 4-year-old Sadie Higuera of California, who had tumors shrink from medical cannabis and a tumor on her liver disappear.
“The tumors are believed to have been removed due to her cannabis use in which [a brand of] CBD (called Real Scientific Hemp Oil) was a major portion of the cannabinoids in her oil along with THC and CBN,” said Brian Higuera, Sadie’s father. “[But] without a study to prove the cannabis oil is what caused the tumors to disappear, many say she is an anecdotal testimony.”
Rob Davidson, CEO of CURE, wants to find hard
... read more at: https://www.civilized.life/articles/cannabis-cancer-study-disappear/